Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine for VATS analgesia
NCT03731221Phase 1Completed
- Sponsor
- Cleveland Clinic
- Start
- Nov 2018
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of bupivacaine in postoperative pain, sponsored by Cleveland Clinic. Primary endpoint: Overall benefit of analgesia score at 3 days. Started Nov 2018; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03731221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03731221.